id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-317519-yhzv2yjs	Barzilai, Nir	Geroscience in the Age of COVID-19	2020-07-23		.txt	text/plain	2595	88	31	Healthy aging: the ultimate preventative medicine Immunosenescence: emerging challenges for an ageing population Benefits of metformin in attenuating the hallmarks of aging Metformin as a tool to target aging Metformin: historical overview Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis Observational study of metformin and risk of mortality in patients hospitalized with Covid-19 mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells mTOR inhibition improves immune function in the elderly TORC1 inhibition enhances immune function and reduces infections in the elderly A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: immunological, physical performance, and cognitive effects Rapamycin for longevity: opinion article Innate and adaptive immunity in aging and longevity: the foundation of resilience Quantification of biological aging in young adults Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area Renin-Angiotensin-Aldosterone system inhibitors in patients with Covid-19 Strategies and challenges in clinical trials targeting human aging Recognizing degenerative aging as a treatable medical condition: methodology and policy Measuring biological aging in humans: a quest The critical need to promote research of aging and aging-related diseases to improve health and longevity of the elderly population Aging health and R&D for healthy longevity must be included into the WHO Work Program Strategies must be developed for periodic frailty assessment with continuous longitudinal follow-up of older persons which may reveal not only global determinants that are conserved, but also local singularities involved in differential aging health around the world.	cache/cord-317519-yhzv2yjs.txt	txt/cord-317519-yhzv2yjs.txt
